Iterum Therapeutics faces Nasdaq non-compliance issue
Iterum Therapeutics plc (NASDAQ:ITRM), a pharmaceutical company with a market capitalization of $53.43 million, has reported a regulatory compliance issue with the Nasdaq Stock Market. According to ...
pharmaphorum3d
How pharma can improve regulatory compliance with AI-based technology
To maintain compliance with constantly shifting regulations, pharmaceutical companies need tools that enable them to discover, highlight, and extract key data within regulatory documents.
Reuters1mon
Pharma digs in on changes it wants from Trump administration
SAN FRANCISCO, Jan 16 (Reuters) - The pharmaceutical industry ... United Statescategory Gabbard confirmed as US intel chief in latest victory for Trump 9:23 PM UTC · Updated ago U.S ...
Impacts11d
Innovations in Pharmaceutical Cybersecurity: Safeguarding Data and Compliance
In the rapidly evolving digital era, the pharmaceutical industry faces significant cybersecurity challenges, where data ...
Supply Chain5d
U.S. Pharma Companies Weigh a Shift to North America — and Possibly the U.S. — for Drug Production
Can the U.S. pharmaceutical supply chain come home — or, at least, get closer to it? The COVID-19 pandemic was just the latest in a series of health crises that are awakening the pharma industry to ...
Yahoo Finance28d
Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica
Demand for compliance-focused CRM solutions in regulatory ... Data security concerns in cloud-based CRM solutions for pharmaceuticals. Customization difficulties for niche biotech applications ...